EU-wide study
Guidance on methodologies to assess the performance of vaccination programmes
This study aims to support EU Member States with guidance on methodologies for the monitoring of the performance of national/regional vaccination programmes and services. Data is collected across four areas of vaccination programme monitoring: vaccination coverage, attitudes towards vaccines and acceptability, vaccine safety and vaccine effectiveness. The study will identify good practices and develop a set of recommendations with the goal of improving the methodologies used to monitor the performance of vaccination programmes in EU countries.




Timeline
Key milestones until February 2024
Literature Review
October 2022 – January 2023
To develop a mapping framework, benchmark and identify ‘good practice’ and current monitoring indicators.
Survey
December 2022- February 2023
Populated by public health authorities to further map current methodologies used to monitor vaccine programmes in each Member State.
Interviews
February - April 2023
With public health authorities, programme implementers and other experts to understand the experience of applying the various methodologies in a different context.
Case Studies
April - July 2023
A deeper dive into the literature and more rigorous gathering of supporting evidence for enablers, barriers and the impact of different contexts.
Sense-making exercise
20th June 2023
A review of the collected data by selected key stakeholders and preliminary recommendations forming.
Preliminary study results
28 August 2023
A review of the preliminary study results by stakeholders and conference participants.
High-level conference
28 September 2023
A one-day hybrid conference in Brussels for public health authorities from all Member States and other experts to further develop a set of recommendations.
Final study results
November 2023 - February 2024
Finalised study results (set of recommendations) in November 2023. Dissemination of recommendations in all official EU languages to all Member States in early 2024.